English
Back
Download
Log in to access Online Inquiry
Back to the Top

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
17K Views
Comment
Sign in to post a comment
    Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
    538
    Followers
    42
    Following
    1940
    Visitors
    Follow